We sought to determine which cell types mediate IL-13-induced airway inflammation.
We treated the airways of mice with IL-13 alone or in combination with IFN-纬. We associated the inhibitory effect of IFN-纬 on IL-13-induced airway inflammation and chemokine production with cell types in the lung that coexpress IL-13 and IFN-纬 receptors. We then evaluated IL-13-induced responses in CD11c promoter-directed diphtheria toxin receptor-expressing mice that were depleted of both dendritic cells and alveolar macrophages and in CD11b promoter-directed diphtheria toxin receptor-expressing mice that were depleted of dendritic cells.
Dendritic cell and alveolar macrophage depletion protected mice from IL-13-induced airway inflammation and CCL11, CCL24, CCL22, and CCL17 chemokine production. Preferential depletion of dendritic cells protected mice from IL-13-induced airway inflammation and CCL22 and CCL17 chemokine production but not from IL-13-induced CCL11 and CCL24 chemokine production. In either case mice were not protected from IL-13-induced AHR and mucus metaplasia.
Pulmonary dendritic cells and alveolar macrophages mediate IL-13-induced airway inflammation and chemokine production.